Yong-Seog Park

Yong-Seog Park

Auto-generated profile, based on publicly available information

Yong-Seog Park

Laboratory of Reproductive Medicine, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
YPYong-Seog Park
Yong-Seog Park
Sun-Hee LeeSun-Hee Lee
Sun-Hee Lee
HCHye Won Choi
Hye Won Choi
HLHyo Serk Lee
Hyo Serk Lee
JLJoong Shik Lee
Joong Shik Lee
JSJu Tae Seo
Ju Tae Seo
Park YS, et al. World J Mens Health. 2018 Jan;36:e25. https://doi.org/10.5534/wjmh.180014

12 May 2015 in Systems Biology in Reproductive Medicine
Verified
Journal Article
Closed access
PDF file
YPYong-Seog Park
Yong-Seog Park
SLSun-Hee Lee
Sun-Hee Lee
CLChun Kyu Lim
Chun Kyu Lim
JCJae Won Cho
Jae Won Cho
KYKwang Moon Yang
Kwang Moon Yang
JSJu Tae Seo
Ju Tae Seo
This study was performed to assess and compare the outcomes of testicular sperm extraction (TESE)-intracytoplasmic sperm injection (ICSI) using spermatozoa from fresh and frozen testicular tissue from men with subgroups of non-obstructive azoospermia (NOA). A total of 110 cycles of TESE-ICSI were performed. Patients were classified into one of the following NOA subgroups: hypospermatogenesis (HS), maturation arrest (MA), or Sertoli cell-only syndrome (SCO). Laboratory (fertilization, cleavage stage of embryo, and good quality embryo) and clinical (pregnancy, clinical pregnancy, implantation, and delivery) outcomes were assessed. No statistically significant differences were observed in any of the other measured parameters between the three subgroups of NOA. No significant differences in laboratory outcomes were observed between spermatozoa from fresh and frozen testicular spermatozoa; however, statistically significant differences were observed in the pregnancy and implantation rates between groups (p < 0.05). The outcomes of using spermatozoa retrieved from fresh testicular tissue in each of the three subgroups were also compared; although clinical outcomes showed low results, no significant differences were observed between the three subgroups. Similarly, no significant differences were observed in spermatozoa retrieved from frozen testicular tissue. Once spermatozoa have been successfully obtained, acceptable laboratory outcomes can be achieved for NOA, whether or not the spermatozoa are cryopreserved. However, satisfactory clinical outcomes may be more difficult to achieve as the results showed in each group of fresh and frozen testicular spermatozoa. Therefore, achieving acceptable clinical pregnancy results and efficient cryopreservation of testicular spermatozoa should be considered in patients with NOA.

1 January 2011 in Clinical and Experimental Reproductive Medicine
Verified
Journal Article
Open access
PDF file
YPYong-Seog Park
Yong-Seog Park
MKMyo Kyung Kim
Myo Kyung Kim
SLSun-Hee Lee
Sun-Hee Lee
JCJae Won Cho
Jae Won Cho
ISIn Ok Song
In Ok Song
JSJu Tae Seo
Ju Tae Seo
Park YS, et al. Clin Exp Reprod Med. 2011 Sep;38(3):142-147. http://dx.doi.org/10.5653/cerm.2011.38.3.142

13 July 2017 in Andrologia
Verified
Journal Article
Closed access
PDF file
YPY. S. Park
Y. S. Park
SLS. H. Lee
S. H. Lee
CLC. K. Lim
C. K. Lim
HCH. W. Choi
H. W. Choi
JAJ. H. An
J. H. An
JSJ. T. Seo
J. T. Seo

1 January 2014 in Clinical and Experimental Reproductive Medicine
Verified
Journal Article
Open access
PDF file
YPYong-Seog Park
Yong-Seog Park
SPSol Park
Sol Park
DKDuck Sung Ko
Duck Sung Ko
DPDong Wook Park
Dong Wook Park
JSJu Tae Seo
Ju Tae Seo
KYKwang Moon Yang
Kwang Moon Yang
Park YS, et al. Clin Exp Reprod Med. 2014 Sep;41(3):132-136. http://dx.doi.org/10.5653/cerm.2014.41.3.132

1 January 2016 in Clinical and Experimental Reproductive Medicine
Verified
Journal Article
Open access
HCHye Won Choi
Hye Won Choi
YPYong-Seog Park
Yong-Seog Park
SLSun-Hee Lee
Sun-Hee Lee
CLChun Kyu Lim
Chun Kyu Lim
JSJu Tae Seo
Ju Tae Seo
KYKwang Moon Yang
Kwang Moon Yang
The aim of this study was to evaluate the influence of maternal age on fertilization, embryo quality, and clinical pregnancy in patients undergoing intracytoplasmic sperm injection (ICSI) using testicular sperm from partners with azoospermia. A total of 416 ICSI cycles using testicular spermatozoa from partners with obstructive azoospermia (OA, n=301) and non-obstructive azoospermia (NOA, n=115) were analyzed. Female patients were divided into the following age groups: 27 to 31 years, 32 to 36 years, and 37 to 41 years. The rates of fertilization, high-quality embryos, clinical pregnancy, and delivery were compared across maternal age groups between the OA and NOA groups. The rates of fertilization and high-quality embryos were not significantly different among the maternal age groups. Similarly, the clinical pregnancy and delivery rates were not significantly different. The fertilization rate was significantly higher in the OA group than in the NOA group (p<0.05). Age-group analysis revealed that the fertilization and high-quality embryo rates were significantly different between the OA and NOA groups in patients aged 27 to 31 years old, but not for the other age groups. Although the clinical pregnancy and delivery rates differed between the OA and NOA groups across all age groups, significant differences were not observed. In couples using testicular sperm from male partners with azoospermia, pregnancy and delivery outcomes were not affected by maternal age. However, women older than 37 years using testicular sperm from partners with azoospermia should be advised of the increased incidence of pregnancy failure.